1-20 of 36
Gunilla Enblad
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Temporal Trends in Relative Survival of Diffuse Large B-Cell Lymphoma in Sweden and Denmark in the Era of Targeted and Cellular Therapies: A Population-Based Binational Study

Sara Harrysson, Sandra Eloranta, Stefanie Antonilli, Mikkel Runason Simonsen, Kristina Sonnevi, Peter de Nully Brown, Bjorn E Wahlin, P-O Andersson, Judit Mészáros Joergensen, Mats Jerkeman, Christian Bjørn Poulsen, Gunilla Enblad, Tarec Christoffer El-Galaly, Karin Ekstroem Smedby
Journal: Blood
Blood (2024) 144 (Supplement 1): 654.
https://doi.org/10.1182/blood-2024-201964
Published: 2024
Journal Articles

Plasma Proteomic Profiling Identifies Prognostic Biomarkers in Mantle Cell Lymphoma

Tove Selvin, Patrick Nylund, Ann-Marie Ly, Anna Nikkarinen, Mattias Berglund, Kossi D Abalo, Daniel Molin, Gunilla Enblad, Peter Hollander, Mats Hellström, Ingrid Glimelius
Journal: Blood
Blood (2024) 144 (Supplement 1): 1623.
https://doi.org/10.1182/blood-2024-209805
Published: 2024
Journal Articles

Rule-Based Machine Learning Analysis of the Blood Proteome Identifies MCL Patients with High Risk of Early Disease Progression

Patrick Nylund, Kossi D Abalo, Saima Zubair, Eirini Voutsinou, Tove Selvin, Ann-Marie Ly, Anna Nikkarinen, Mattias Berglund, Daniel Molin, Gunilla Enblad, Peter Hollander, Mats Hellström, Ingrid Glimelius
Journal: Blood
Blood (2024) 144 (Supplement 1): 2995.
https://doi.org/10.1182/blood-2024-204816
Published: 2024
Journal Articles

Plasma Proteomics Differentiates between Patients with B-Cell Lymphomas

Haris Babačić, Nashif Mahruf Chowdhury, Mattias Berglund, Jamileh Hashemi, Jeremia Collin, Emma Pettersson, Ann-Marie Ly, Anna Nikkarinen, Gunilla Enblad, Daniel Molin, Ingrid Glimelius, Maria Pernemalm, Mats Hellström
Journal: Blood
Blood (2024) 144 (Supplement 1): 4370.
https://doi.org/10.1182/blood-2024-204083
Published: 2024
Journal Articles

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Clinical Trials & Observations
Mahmoud Elsawy, Julio C. Chavez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob D. Rudzki, Saurabh Dahiya, Kathleen Dorritie, Samantha Jaglowski, John Radford, Franck Morschhauser, David Cunningham, Alejandro Martin Garcia-Sancho, Dimitrios Tzachanis, Matthew L. Ulrickson, Reem Karmali, Natasha Kekre, Catherine Thieblemont, Gunilla Enblad, Peter Dreger, Ram Malladi, Namita Joshi, Wei-Jhih Wang, Caitlyn T. Solem, Julia Thornton Snider, Paul Cheng, Christina To, Marie José Kersten
Journal: Blood
Blood (2022) 140 (21): 2248–2260.
https://doi.org/10.1182/blood.2022015478
Published: 2022
Includes: Supplemental data
Journal Articles

Long Follow-up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma (RATHL) Trial (CRUK/07/033) Confirms the Safety of Both De-Escalation and Intensification of Chemotherapy

Stefano Luminari, Alexander Fosså, Judith Trotman, Daniel Molin, Francesco Annibale d'Amore, Gunilla Enblad, Leanne Berkahn, Sally F Barrington, John Radford, Massimo Federico, Amy A. Kirkwood, Peter Johnson
Journal: Blood
Blood (2022) 140 (Supplement 1): 766–767.
https://doi.org/10.1182/blood-2022-162780
Published: 2022
Journal Articles

Treatment Sequencing and Survival in Follicular Lymphoma: A National Population-Based Study

Tove Wästerlid, Anna Warnqvist, Caroline E. Weibull, Björn E Wahlin, P-O Andersson, Gunilla Enblad, Eva Kimby, Karin Ekstroem Smedby
Journal: Blood
Blood (2022) 140 (Supplement 1): 3620–3621.
https://doi.org/10.1182/blood-2022-164550
Published: 2022
Journal Articles

Patient-Reported Outcomes in a Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard of Care Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma (ZUMA-7)

Mahmoud Elsawy, Julio C. Chavez, Irit Avivi, Jean-François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob D. Rudzki, Saurabh Dahiya, Kathleen Dorritie, Samantha Jaglowski, John Radford, Franck Morschhauser, David Cunningham, Alejandro Martin Garcia-Sancho, Dimitrios Tzachanis, Matthew L. Ulrickson, Reem Karmali, Natasha Kekre, Catherine Thieblemont, Gunilla Enblad, Peter Dreger, Ram Malladi, Namita Joshi, Wei-Jhih Wang, Caitlyn T. Solem, Julia Thornton Snider, Christina To, Marie José Kersten
Journal: Blood
Blood (2021) 138 (Supplement 1): 430.
https://doi.org/10.1182/blood-2021-147598
Published: 2021
Journal Articles

Evaluation of Eligibility for CAR-T Cell Therapy in a Population-Based Cohort of 3550 Patients with Incident Diffuse Large B-Cell Lymphoma (DLBCL) in Sweden

Karin Ekstroem Smedby, Sara Harrysson, MD, Sara Ekberg, Mats Jerkeman, MD PhD, Per-Ola Andersson, MD PhD, Gunilla Enblad, Sandra Eloranta
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-138737
Published: 2020
Journal Articles

Outcome By Primary Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A Large, Population-Based Study in Sweden

Caroline Weibull, Björn E Wahlin, MD PhD, Sandra Lockmer, Gunilla Enblad, Per-Ola Andersson, MD PhD, Eva Kimby, MD PhD, Karin E. Smedby, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-140228
Published: 2020
Journal Articles

Incidence of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Including CNS Relapse in a Population-Based Cohort of 4205 Patients in Sweden

Sara Harrysson, MD, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, MD Professor, Sverker Hasselblom, Björn E Wahlin, MD PhD, Per-Ola Andersson, MD PhD, Karin E. Smedby, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 399.
https://doi.org/10.1182/blood-2019-122014
Published: 2019
Journal Articles

Treatment Intensity, Timing of Relapse and Outcome of 713 Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Setting in Sweden

Karin Ekstrom Ekstroem Smedby, Sara Ekberg, Sandra Eloranta, Gunilla Enblad, Mats Jerkeman, MD Professor, Per-Ola Andersson, MD PhD, Sara Harrysson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4111.
https://doi.org/10.1182/blood-2019-123785
Published: 2019
Journal Articles

Quantitative Proteomics in Diffuse Large B-Cell Lymphoma Patients Reveal Novel Overexpressed Proteins and Potentially Druggable Targets in the ABC Subtype

Susanne Bram Ednersson, MD, Mimmie Stern, MD, Henrik Fagman, Gunilla Enblad, Ulf-Henrik Mellqvist, MD PhD, Herman Nilsson-Ehle, MD PhD, Sverker Hasselblom, Per-Ola Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3967.
https://doi.org/10.1182/blood-2019-126387
Published: 2019
Journal Articles

Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Karin Ekstrom Smedby, MD PhD, Sara Harrysson, MD, Per-Ola Andersson, Gunilla Enblad, Sara Ekberg, Mats Jerkeman, Sandra Eloranta
Journal: Blood
Blood (2018) 132 (Supplement 1): 4200.
https://doi.org/10.1182/blood-2018-99-116343
Published: 2018
Journal Articles

Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

Sara Harrysson, MD, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Mats Jerkeman, Sverker Hasselblom, Björn E Wahlin, Per-Ola Andersson, Karin E Smedby
Journal: Blood
Blood (2018) 132 (Supplement 1): 2975.
https://doi.org/10.1182/blood-2018-99-110672
Published: 2018
Journal Articles

Six Cycles of R-CHOP-21 Is Non-Inferior to 8 Cycles for Treatment of Diffuse Large B-Cell Lymphoma - a Nordic Lymphoma Group Population Based Study

Tove Wästerlid, MD PhD, Jorne Lionel Biccler, MSc, Peter de Nully Brown, MD PhD, Jacob Haaber Christensen, MD PhD, Gunilla Enblad, MD PhD, Judit Mészáros Jørgensen, Karin E Smedby, MD PhD, Tarec Christoffer El-Galaly, MD PhD, Mats Jerkeman, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1560.
https://doi.org/10.1182/blood.V130.Suppl_1.1560.1560
Published: 2017
Journal Articles

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

Clinical Trials & Observations Brief Report
Larry Mansouri, Daniel Noerenberg, Emma Young, Elena Mylonas, Maysaa Abdulla, Mareike Frick, Fazila Asmar, Viktor Ljungström, Markus Schneider, Kenichi Yoshida, Aron Skaftason, Tatjana Pandzic, Blanca Gonzalez, Anna Tasidou, Nils Waldhueter, Alfredo Rivas-Delgado, Maria Angelopoulou, Marita Ziepert, Christopher Maximilian Arends, Lucile Couronné, Dido Lenze, Claudia D. Baldus, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga D. Munch-Petersen, Thorsten Zenz, Martin-Leo Hansmann, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Martin Erlanson, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Seishi Ogawa, Ralf Küppers, Kostas Stamatopoulos, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, Elias Campo, Rose-Marie Amini, German Ott, Theodoros P. Vassilakopoulos, Michael Hummel, Richard Rosenquist, Frederik Damm
Journal: Blood
Blood (2016) 128 (23): 2666–2670.
https://doi.org/10.1182/blood-2016-03-704528
Published: 2016
Includes: Supplemental data
Journal Articles

ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma

Daniel Noerenberg*, Larry Mansouri*, Emma Young, Frick Mareike, Maysaa Abdulla, Fazila Asmar, Blanca Gonzalez-Farre, Tasidou Anna, Nils Waldhueter, Viktor Ljungström, Alfredo Rivas, Maria K. Angelopoulou, Marita Ziepert, Christopher M. Arends, Lucile Couronne, Dido Lenze, Claudia D. Baldus, MD, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga Duverger Munch-Petersen, Thorsten Zenz, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Kostas Stamatopoulos, MD PhD, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, MD, Elias Campo, Rose-Marie Amini, German Ott, Theodoros Vassilakopoulos, Michael Hummel, Frederik Damm**, Richard Rosenquist**
Journal: Blood
Blood (2016) 128 (22): 609.
https://doi.org/10.1182/blood.V128.22.609.609
Published: 2016
Journal Articles

Overexpression of Ribosomal Proteins Is Associated with Resistance to Immunochemotherapy in Diffuse Large B-Cell Lymphoma Patients

Martin Stenson, MD, Susanne Bram-Ednersson, MD, Herman Nilsson-Ehle, MD PhD, Mimmie Stern, MD, Gunilla Enblad, Sverker Hasselblom, MD PhD, Per-Ola Andersson, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4121.
https://doi.org/10.1182/blood.V128.22.4121.4121
Published: 2016
Journal Articles

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

Konstantinos Georgiou, Longyun Chen, Mattias Berglund, Weicheng Ren, Noel F. C. C. de Miranda, Susana Lisboa, Marco Fangazio, Shida Zhu, Yong Hou, Kui Wu, Wenfeng Fang, Xianhuo Wang, Bin Meng, Li Zhang, Yixin Zeng, Govind Bhagat, Magnus Nordenskjöld, Christer Sundström, Gunilla Enblad, Riccardo Dalla-Favera, Huilai Zhang, Manuel R. Teixeira, Laura Pasqualucci, Roujun Peng, Qiang Pan-Hammarström
Journal: Blood
Blood (2016) 127 (24): 3026–3034.
https://doi.org/10.1182/blood-2015-12-686550
Published: 2016
Includes: Supplemental data